Mykofungin 3 (Clotrimazole)

Clotrimazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. Disruption of ergosterol production weakens the fungal cell membrane, leading to increased permeability and cell death, thereby clearing the infection.

The dosage regimen for Mykofungin 3 is determined by the prescribing healthcare professional based on the severity of infection and patient-specific factors. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for clotrimazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mykofungin 3.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Clotrimazole, the active ingredient in Mykofungin 3, belongs to the azole class and is widely used for topical treatment of vaginal yeast infections. Compared with polyene agents such as nystatin, azoles generally have a broader spectrum, better tolerability and convenient dosing, though choice depends on individual patient factors.

Store Mykofungin 3 at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mykofungin 3 is applied intravaginally. The patient inserts the tablet or pessary into the vagina as directed by the prescriber, usually at bedtime, and follows the recommended duration of therapy to achieve optimal results.

Serious adverse reactions are rare but may include severe allergic responses such as rash, hives, or Stevens‑Johnson syndrome, as well as significant vulvar swelling. Any signs of a serious reaction require immediate medical attention.

Individuals with a known hypersensitivity to clotrimazole, other azole antifungals, or any component of the formulation should avoid using Mykofungin 3. Patients with severe liver disease should consult a healthcare professional before use.